Jun 15, 2020
Mymee Appoints Melinda Decker as Chief Commercial Officer
Jun 06, 2020
AbbVie Presents Data Showing RINVOQ(TM) (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Head-to-Head Study Versus ORENCIA (abatacept) in Rheumatoid Arthritis Patients
Jun 04, 2020
Therapeutic Solutions International Announces Positive Preclinical and Clinical Evaluation of Nutritional Supplement QuadraMune(TM), Designed to Protect Against COVID-19
Jun 04, 2020
New Long-term Data from RINVOQ(TM) (upadacitinib, 15 mg) Phase 3 Studies in Rheumatoid Arthritis Presented at 2020 Annual European E-Congress of Rheumatology (EULAR)
Apr 25, 2020
Advisory - Chloroquine and hydroxychloroquine can have serious side effects. These drugs should be used only under the supervision of a physician
Apr 20, 2020
COVID-19 Update - Hydroxychloroquine Market was Estimated to be US$ 41.3 Mn in 2018 and is Growing at a CAGR of 10.4% Over the Forecast Period, Owing to Increasing Demand for Medications to Treat Autoimmune Diseases, Says Absolute Markets Insights
Apr 15, 2020
Mallinckrodt Announces Publication of Data on Acthar® Gel (Repository Corticotropin Injection) from its Randomized, Double-Blind, Placebo-Controlled Phase 4 Study in Rheumatoid Arthritis (RA) in Rheumatology and Therapy
Mar 20, 2020
New Research Among People Living With Rheumatoid Arthritis Reveals Key Determinants Of Patient Satisfaction With Doctors
Feb 18, 2020
Arthritis Foundation Releases Findings From One of the Nation's Largest Assessments of People With Arthritis
Nov 21, 2019
Electroceuticals World Market Study, 2019: Coverage of Epilepsy, Cardiovascular Diseases, Rheumatoid Arthritis & Diabetes Treatment Using Electroceuticals
Nov 21, 2019
Araim Pharmaceuticals Selects Ferry Breedveld as Acting CEO
Nov 12, 2019
Trio Health Reports on Outpatient Costs for Individuals with Rheumatoid Arthritis (RA) Treated in the U.S. Community Practices
Nov 12, 2019
Mallinckrodt Announces New Clinical Data Evaluating Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2019 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual Meeting
Nov 08, 2019
Global $18 Billion Autoimmune Disease Diagnostic Markets to 2026
Nov 06, 2019
Pain Relief Options for Rheumatoid Arthritis-Associated Chronic Back Pain
Oct 03, 2019
Regen BioPharma Successfully Treats Rheumatoid Arthritis Using Cannabidiol (CBD) Based Immune Modulatory Treatments
Sep 24, 2019
Arthritis Foundation Releases First CBD Guidance for Adults With Arthritis
Sep 17, 2019
Rheumatologist Dr. Jenny Gartshteyn Joins CORE Medical & Wellness in Lyndhurst, NJ
Sep 05, 2019
How Common are Mental Health Problems in Arthritis Patients? Research Reveals Flaw in Determining Extent of Problem
Aug 05, 2019
The global rheumatoid arthritis diagnostic devices market at a CAGR of almost 6% during the forecast period